Geode Capital Management
TRAW icon

Geode Capital Management’s Traws Pharma TRAW Stock Holding History

Geode Capital Management’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$141K Buy
77,103
+15,450
+25% +$29K ﹤0.01% 4030
2025
Q4 		$69.7K Buy
61,653
+18,213
+42% +$40.5K ﹤0.01% 4173
2025
Q3 		$80.4K Buy
43,440
+7,715
+22% +$12.6K ﹤0.01% 4180
2025
Q2 		$52.9K Buy
35,725
+2,346
+7% +$3.74K ﹤0.01% 4204
2025
Q1 		$76.8K Buy
33,379
+12,578
+60% +$65.4K ﹤0.01% 4101
2024
Q4 		$185K Buy
+20,801
New +$116K ﹤0.01% 3928
2024
Q3 		– Sell
-8,963
Closed -$100K – 4587
2024
Q2 		$100K Buy
8,963
+1,249
+16% +$20.1K ﹤0.01% 4141
2024
Q1 		$195K Hold
7,714
– – ﹤0.01% 3948
2023
Q4 		$144K Hold
7,714
– – ﹤0.01% 4057
2023
Q3 		$139K Buy
7,714
+934
+14% +$21.3K ﹤0.01% 4128
2023
Q2 		$200K Hold
6,780
– – ﹤0.01% 4039
2023
Q1 		$124K Hold
6,780
– – ﹤0.01% 4259
2022
Q4 		$109K Sell
6,780
-14
-0.2% -$264 ﹤0.01% 4368
2022
Q3 		$149K Hold
6,794
– – ﹤0.01% 4370
2022
Q2 		$224K Buy
6,794
+275
+4% +$9.28K ﹤0.01% 4193
2022
Q1 		$299K Hold
6,519
– – ﹤0.01% 4186
2021
Q4 		$415K Sell
6,519
-578
-8% -$46.5K ﹤0.01% 4145
2021
Q3 		$679K Buy
7,097
+1,378
+24% +$177K ﹤0.01% 3882
2021
Q2 		$990K Buy
5,719
+208
+4% +$47.1K ﹤0.01% 3608
2021
Q1 		$2.06M Buy
5,511
+2,076
+60% +$783K ﹤0.01% 3239
2020
Q4 		$600K Buy
3,435
+1,026
+43% +$119K ﹤0.01% 3538
2020
Q3 		$252K Buy
2,409
+1,004
+71% +$248K ﹤0.01% 3642
2020
Q2 		$298K Buy
1,405
+154
+12% +$23.5K ﹤0.01% 3545
2020
Q1 		$142K Buy
1,251
+1,125
+893% +$177K ﹤0.01% 3650
2019
Q4 		$18K Hold
126
– – ﹤0.01% 4167
2019
Q3 		$40K Hold
126
– – ﹤0.01% 4087
2019
Q2 		$135K Buy
126
+32
+34% +$44.1K ﹤0.01% 3884
2019
Q1 		$115K Buy
94
+24
+34% +$28.5K ﹤0.01% 3864
2018
Q4 		$55K Hold
70
– – ﹤0.01% 3974
2018
Q3 		$191K Buy
70
+44
+169% +$112K ﹤0.01% 3779
2018
Q2 		$58K Buy
+26
New +$75.5K ﹤0.01% 3963
2016
Q2 		– Sell
-1
Closed -$26 – 4081
2016
Q1 		$26 Hold
1
– – ﹤0.01% 4037
2015
Q4 		$44K Hold
1
– – ﹤0.01% 4023
2015
Q3 		$62K Hold
1
– – ﹤0.01% 3989
2015
Q2 		$108K Hold
1
– – ﹤0.01% 3754
2015
Q1 		$110K Hold
1
– – ﹤0.01% 3745
2014
Q4 		$150K Hold
1
– – ﹤0.01% 3688
2014
Q3 		$122K Hold
1
– – ﹤0.01% 3708
2014
Q2 		$153K Hold
1
– – ﹤0.01% 3595
2014
Q1 		$197K Hold
1
– – ﹤0.01% 3492
2013
Q4 		$348K Hold
1
– – ﹤0.01% 3235
2013
Q3 		$763K Buy
+1
New +$1.43M ﹤0.01% 2738

Other funds holding TRAW

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Geode Capital Management's TRAW Position: Q1 2026 in Review

Geode Capital Management increased its Traws Pharma (TRAW) stake by 25% in Q1 2026, buying an estimated $29K and bringing the position to 77,103 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #4030.

Geode Capital Management first reported a position in TRAW in Q3 2013 and has held it in 42 quarters since. The position peaked at $2.06M in Q1 2021. 28 funds tracked by Wall St. Rank hold TRAW as of Q1 2026.

  • Geode Capital Management held 77,103 shares of Traws Pharma worth $141K as of Q1 2026.
  • Geode Capital Management bought 15,450 Traws Pharma shares in Q1 2026, an estimated $29K.
  • Traws Pharma made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4030 holding.
  • Geode Capital Management first reported a position in Traws Pharma in Q3 2013 and has held it in 42 quarters since.
  • Geode Capital Management's Traws Pharma position peaked at $2.06M in Q1 2021.
  • 28 funds tracked by Wall St. Rank held Traws Pharma as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.